Safe and effective medicines for children : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /

Safe and effective medicines for children : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.

Saved in:
Bibliographic Details
:
Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
TeilnehmendeR:
Field, Marilyn J.
Boat, Thomas F.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
Year of Publication:2012
Language:English
Online Access:
Physical Description:xxiii, 408 p.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5003564276
ctrlnum (MiAaPQ)5003564276
(Au-PeEL)EBL3564276
(CaPaEBR)ebr10606357
(CaONFJC)MIL394880
(OCoLC)813285771
collection bib_alma
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01868nam a2200385Ia 4500</leader><controlfield tag="001">5003564276</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">120711s2012 dcu sb 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309225496</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309225493</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003564276</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3564276</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10606357</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL394880</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)813285771</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RJ560</subfield><subfield code="b">.C666 2012</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Safe and effective medicines for children</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /</subfield><subfield code="c">Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxiii, 408 p.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pediatric pharmacology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Safety measures.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Field, Marilyn J.</subfield><subfield code="q">(Marilyn Jane)</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boat, Thomas F.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Board on Health Sciences Policy.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Academies Press (U.S.)</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564276</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>
record_format marc
spelling Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
Safe and effective medicines for children [electronic resource] : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.
Washington : National Academies Press, 2012.
xxiii, 408 p.
Includes bibliographical references and index.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Pediatric pharmacology.
Drugs Safety measures.
Electronic books.
Field, Marilyn J. (Marilyn Jane)
Boat, Thomas F.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564276 Click to View
language English
format Electronic
eBook
author2 Field, Marilyn J.
Boat, Thomas F.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
author_facet Field, Marilyn J.
Boat, Thomas F.
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
author2_variant m j f mj mjf
t f b tf tfb
author2_fuller (Marilyn Jane)
author2_role TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
author_corporate Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
Institute of Medicine (U.S.). Board on Health Sciences Policy.
National Academies Press (U.S.)
ProQuest (Firm)
author_sort Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA)
title Safe and effective medicines for children pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /
spellingShingle Safe and effective medicines for children pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /
title_sub pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /
title_full Safe and effective medicines for children [electronic resource] : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.
title_fullStr Safe and effective medicines for children [electronic resource] : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.
title_full_unstemmed Safe and effective medicines for children [electronic resource] : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Board on Health Sciences Policy; Marilyn J. Field and Thomas F. Boat, editors.
title_auth Safe and effective medicines for children pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /
title_new Safe and effective medicines for children
title_sort safe and effective medicines for children pediatric studies conducted under the best pharmaceuticals for children act and the pediatric research equity act /
publisher National Academies Press,
publishDate 2012
physical xxiii, 408 p.
callnumber-first R - Medicine
callnumber-subject RJ - Pediatrics
callnumber-label RJ560
callnumber-sort RJ 3560 C666 42012
genre Electronic books.
genre_facet Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564276
illustrated Not Illustrated
oclc_num 813285771
work_keys_str_mv AT committeeonpediatricstudiesconductedunderthebestpharmaceuticalsforchildrenactbpcaandthepediatricresearchequityactprea safeandeffectivemedicinesforchildrenpediatricstudiesconductedunderthebestpharmaceuticalsforchildrenactandthepediatricresearchequityact
AT fieldmarilynj safeandeffectivemedicinesforchildrenpediatricstudiesconductedunderthebestpharmaceuticalsforchildrenactandthepediatricresearchequityact
AT boatthomasf safeandeffectivemedicinesforchildrenpediatricstudiesconductedunderthebestpharmaceuticalsforchildrenactandthepediatricresearchequityact
AT instituteofmedicineusboardonhealthsciencespolicy safeandeffectivemedicinesforchildrenpediatricstudiesconductedunderthebestpharmaceuticalsforchildrenactandthepediatricresearchequityact
AT nationalacademiespressus safeandeffectivemedicinesforchildrenpediatricstudiesconductedunderthebestpharmaceuticalsforchildrenactandthepediatricresearchequityact
AT proquestfirm safeandeffectivemedicinesforchildrenpediatricstudiesconductedunderthebestpharmaceuticalsforchildrenactandthepediatricresearchequityact
status_str n
ids_txt_mv (MiAaPQ)5003564276
(Au-PeEL)EBL3564276
(CaPaEBR)ebr10606357
(CaONFJC)MIL394880
(OCoLC)813285771
is_hierarchy_title Safe and effective medicines for children pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
noLinkedField
noLinkedField
_version_ 1792330884989321216

Similar Items